FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4361745362> ?p ?o ?g. }

• W4361745362 endingPage "1892" @default.
• W4361745362 startingPage "1887" @default.
• W4361745362 abstract "No AccessJournal of UrologyPEDIATRIC UROLOGY1 Nov 2001LONG-TERM FOLLOWUP OF CHILDREN TREATED WITH DEXTRANOMER/HYALURONIC ACID COPOLYMER FOR VESICOURETERAL REFLUX GÖRAN LÄCKGREN, NILS WÅHLIN, ERIK SKÖLDENBERG, and ARNE STENBERG GÖRAN LÄCKGRENGÖRAN LÄCKGREN More articles by this author , NILS WÅHLINNILS WÅHLIN More articles by this author , ERIK SKÖLDENBERGERIK SKÖLDENBERG More articles by this author , and ARNE STENBERGARNE STENBERG More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(05)65713-8AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: Dextranomer/hyaluronic acid copolymer is a novel substance that has favorable properties for endoscopic treatment of vesicoureteral reflux. We assess the long-term efficacy and safety of this treatment of children. Materials and Methods: Children 1 to 15 years old with grade III or greater vesicoureteral reflux were eligible for enrollment in our study. All patients received endoscopic treatment with dextranomer/hyaluronic acid copolymer and were scheduled to have a voiding cystourethrogram 3 and 12 months after implantation. Children with reflux grade III or greater after treatment received up to 2 more implantations, and those with persistent reflux were referred for open surgery. In some cases long-term clinical followup was accompanied by a late voiding cystourethrogram. Results: A total of 228 patients received endoscopic treatment. The efficacy population was comprised of 221 children, including 67 who received 2 and 8 who received 3 implantations. Endoscopic treatment was performed without complications in all cases. Patients were followed clinically for 2 to 7.5 years (mean 5). On the last voiding cystourethrogram 68% of patients had a positive response (grade I or less) and 81% had no dilating reflux. The corresponding results for treated ureters were 75% and 85%, respectively. Only 27 (12%) patients were referred for open surgery. A late voiding cystourethrogram was performed in 49 patients 2 to 5 years after treatment. Of the ureters free of reflux (grade 0) 3 to 12 months after treatment 96% remained free of dilating reflux. Adverse events occurred in association with implantation in only 2% of patients, although urinary tract infection subsequently developed in 8%. Conclusions: Endoscopic treatment with dextranomer/hyaluronic acid copolymer was effective and well tolerated in children with vesicoureteral reflux. Long-term followup indicated that there was no deterioration in patients responding positively to treatment. References 1 : Vesico-ureteric reflux: occurrence and long-term risks. Acta Paediatr1999; 431: 22. Google Scholar 2 : Management of recurrent urinary tract infection and vesicoureteral reflux in children. Curr Opin Urol2000; 10: 25. Google Scholar 3 : Long-term followup of infants with gross vesicoureteral reflux. J Urol part 21992; 148: 1709. Abstract, Google Scholar 4 : End-stage reflux nephropathy. Ren Fail1994; 16: 27. Google Scholar 5 : The natural history of reflux and long-term effects of reflux on the kidney. J Urol1976; 115: 728. Link, Google Scholar 6 Medical versus surgical treatment of primary vesicoureteral reflux: report of the International Reflux Study Committee. Pediatrics1981; 67: 392. Google Scholar 7 : Cessation of vesicoureteral reflux for 5 years in infants and children allocated to medical treatment. The International Reflux Study in Children. J Urol part 21992; 148: 1662. Abstract, Google Scholar 8 : Antibacterial prophylaxis in children with urinary tract infection. Acta Paediatr Suppl1999; 88: 48. Google Scholar 9 : Die Behandlung des vesikorenalen Refluxes durch transurethrale Einspritzung von Teflon Paste. Urologe A1981; 20: 263. Google Scholar 10 : Endoscopic treatment of reflux: experimental study and review of Teflon and collagen. Eur Urol1993; 23: 386. Google Scholar 11 : Particulate silicone for use in periurethral injections: local tissue effects and search for migration. J Urol1995; 153: 2039. Link, Google Scholar 12 : Skin migration following periurethral polytetrafluoroethylene injection for urinary incontinence. Aust N Z J Surg1996; 66: 57. Google Scholar 13 : Long-term histological response to intravenous Teflon and silicone in a rat model. Pediatr Surg Int1995; 10: 129. Google Scholar 14 : Induction of malignant fibrous histiocytoma in female Fisher rats by implantation of cyanoacrylate, zirconia, polyvinyl chloride or silicone. In Vivo1993; 7: 111. Google Scholar 15 : Failure of subureteral bovine collagen injection for the endoscopic treatment of primary vesicoureteral reflux in long-term followup. Urology2000; 55: 759. Google Scholar 16 : Association between bovine collagen dermal implants and a dermatomyositis or polymyositis-like syndrome. Ann Intern Med1993; 118: 920. Google Scholar 17 : Injectable dextranomer-based implant: histopathology, volume changes and DNA analysis. Scand J Urol Nephrol1999; 33: 355. Google Scholar 18 : Lack of distant migration after injection of a 125iodine labeled dextranomer based implant into the rabbit bladder. J Urol1997; 158: 1937. Link, Google Scholar 19 : A new bioimplant for the endoscopic treatment of vesicoureteral reflux: experimental and short-term clinical results. J Urol part 21995; 154: 800. Link, Google Scholar 20 : Treatment of vesicoureteric reflux by endoscopic injection of Teflon. Br Med J Clin Res Ed1984; 289: 7. Google Scholar 21 : Complications of vesicoureteral operations from incoordination of micturition. J Urol1976; 116: 638. Link, Google Scholar 22 : Incidence rate of first-time symptomatic urinary tract infection in children under 6 years of age. Acta Paediatr1998; 87: 549. Google Scholar 23 : Urinary tract infection, day wetting and other voiding symptoms in seven- to eight-year-old Danish children. Acta Paediatr1997; 86: 1345. Google Scholar 24 : Endoscopic substances for the treatment of vesicoureteral reflux. Urology1997; 50: 489. Google Scholar From the Section of Urology, University Children’s Hospital, Uppsala, Sweden© 2001 by American Urological Association, Inc.FiguresReferencesRelatedDetailsCited byFiorenza V, Hukkinen M, Alova I, Clermidi P, Broch A, Botto N, Blanc T and Lottmann H (2022) Dextranomer Endoscopic Injections for the Treatment of Urinary Incontinence in Bladder Exstrophy-epispadias ComplexJournal of Urology, Ramsay S, Blais A, Morin F, Moore K, Cloutier J and Bolduc S (2016) Polyacrylamide Hydrogel as a Bulking Agent for the Endoscopic Treatment of Vesicoureteral Reflux: Long-Term Results and SafetyJournal of Urology, VOL. 197, NO. 3 Part 2, (963-967), Online publication date: 1-Mar-2017.Akiki A, Boissier R, Delaporte V, Maurin C, Gaillet S, Karsenty G, Coulange C and Lechevallier E (2018) Endoscopic Treatment of Symptomatic Vesicoureteral Reflux after Renal TransplantationJournal of Urology, VOL. 193, NO. 1, (225-229), Online publication date: 1-Jan-2015.Cloutier J, Blais A, Moore K and Bolduc S (2018) Prospective Study Using a New Bulking Agent for the Treatment of Vesicoureteral Reflux: Polyacrylamide HydrogelJournal of Urology, VOL. 190, NO. 3, (1034-1037), Online publication date: 1-Sep-2013.Kajbafzadeh A and Tourchi A (2018) Usefulness of Concomitant Autologous Blood and Dextranomer/Hyaluronic Acid Copolymer Injection to Correct Vesicoureteral RefluxJournal of Urology, VOL. 188, NO. 3, (948-952), Online publication date: 1-Sep-2012.Sparks S, DeCambre M, Christman M, Kaplan G and Holmes N (2018) Salvage Ureteral Reimplantation After Failure of Dextranomer/Hyaluronic Acid InjectionJournal of Urology, VOL. 186, NO. 1, (257-260), Online publication date: 1-Jul-2011.Cendron M (2011) Editorial CommentJournal of Urology, VOL. 185, NO. 6S, (2540-2540), Online publication date: 1-Jun-2011.Holmdahl G, Brandström P, Läckgren G, Sillén U, Stokland E, Jodal U and Hansson S (2018) The Swedish Reflux Trial in Children: II. Vesicoureteral Reflux OutcomeJournal of Urology, VOL. 184, NO. 1, (280-285), Online publication date: 1-Jul-2010.Ormaechea M, Ruiz E, Denes E, Gimenez F, Dénes F, Moldes J, Amarante A, Pioner G, Dekermacher S and de Badiola F (2018) New Tissue Bulking Agent (Polyacrylate Polyalcohol) for Treating Vesicoureteral Reflux: Preliminary Results in ChildrenJournal of Urology, VOL. 183, NO. 2, (714-718), Online publication date: 1-Feb-2010.Traxel E, DeFoor W, Reddy P, Sheldon C and Minevich E (2009) Risk Factors for Urinary Tract Infection After Dextranomer/Hyaluronic Acid Endoscopic InjectionJournal of Urology, VOL. 182, NO. 4S, (1708-1713), Online publication date: 1-Oct-2009.Nelson C, Copp H, Lai J and Saigal C (2018) Is Availability of Endoscopy Changing Initial Management of Vesicoureteral Reflux?Journal of Urology, VOL. 182, NO. 3, (1152-1157), Online publication date: 1-Sep-2009.Lee E, Gatti J, DeMarco R and Murphy J (2018) Long-Term Followup of Dextranomer/Hyaluronic Acid Injection for Vesicoureteral Reflux: Late Failure Warrants Continued FollowupJournal of Urology, VOL. 181, NO. 4, (1869-1875), Online publication date: 1-Apr-2009.Saperston K, Smith J, Putman S, Matern R, Foot L, Wallis C, deVries C, Snow B and Cartwright P (2008) Endoscopic Subureteral Injection is Not Less Expensive Than Outpatient Open Reimplantation for Unilateral Vesicoureteral RefluxJournal of Urology, VOL. 180, NO. 4S, (1626-1630), Online publication date: 1-Oct-2008.Gupta A and Snodgrass W (2008) Intra-Orifice Versus Hydrodistention Implantation Technique in Dextranomer/Hyaluronic Acid Injection for Vesicoureteral RefluxJournal of Urology, VOL. 180, NO. 4S, (1589-1593), Online publication date: 1-Oct-2008.Dave S, Lorenzo A, Khoury A, Braga L, Skeldon S, Suoub M, Farhat W, Pippi Salle J and Bägli D (2008) Learning From the Learning Curve: Factors Associated With Successful Endoscopic Correction of Vesicoureteral Reflux Using Dextranomer/Hyaluronic Acid CopolymerJournal of Urology, VOL. 180, NO. 4S, (1594-1600), Online publication date: 1-Oct-2008.Callaghan K, Gray E, Caldamone A and Ellsworth P (2018) Factors Involved in Parental Decision Making for Surgical Correction of Vesicoureteral RefluxJournal of Urology, VOL. 180, NO. 2, (701-706), Online publication date: 1-Aug-2008.Elmore J, Kirsch A, Heiss E, Gilchrist A and Scherz H (2018) Incidence of Urinary Tract Infections in Children After Successful Ureteral Reimplantation Versus Endoscopic Dextranomer/Hyaluronic Acid ImplantationJournal of Urology, VOL. 179, NO. 6, (2364-2368), Online publication date: 1-Jun-2008.Knudson M, Austin J, Wald M, Makhlouf A, Niederberger C and Cooper C (2007) Computational Model for Predicting the Chance of Early Resolution in Children With Vesicoureteral RefluxJournal of Urology, VOL. 178, NO. 4S, (1824-1827), Online publication date: 1-Oct-2007.Routh J, Reinberg Y, Ashley R, Inman B, Wolpert J, Vandersteen D, Husmann D and Kramer S (2007) Multivariate Comparison of the Efficacy of Intraureteral Versus Subtrigonal Techniques of Dextranomer/Hyaluronic Acid InjectionJournal of Urology, VOL. 178, NO. 4S, (1702-1706), Online publication date: 1-Oct-2007.Puri P, Mohanan N, Menezes M and Colhoun E (2007) Endoscopic Treatment of Moderate and High Grade Vesicoureteral Reflux in Infants Using Dextranomer/Hyaluronic AcidJournal of Urology, VOL. 178, NO. 4S, (1714-1717), Online publication date: 1-Oct-2007.Routh J, Ashley R, Sebo T, Vandersteen D, Slezak J and Reinberg Y (2007) Histopathological Changes Associated With Dextranomer/Hyaluronic Acid Injection for Pediatric Vesicoureteral RefluxJournal of Urology, VOL. 178, NO. 4S, (1707-1710), Online publication date: 1-Oct-2007.Knudson M, Austin J, McMillan Z, Hawtrey C and Cooper C (2007) Predictive Factors of Early Spontaneous Resolution in Children With Primary Vesicoureteral RefluxJournal of Urology, VOL. 178, NO. 4S, (1684-1688), Online publication date: 1-Oct-2007.Yücel S, Tarcan T and Şimşek F (2018) Durability of a Single Successful Endoscopic Polytetrafluoroethylene Injection for Primary Vesicoureteral Reflux: 14-Year Followup ResultsJournal of Urology, VOL. 178, NO. 1, (265-268), Online publication date: 1-Jul-2007.Yucel S, Gupta A and Snodgrass W (2018) Multivariate Analysis of Factors Predicting Success With Dextranomer/Hyaluronic Acid Injection for Vesicoureteral RefluxJournal of Urology, VOL. 177, NO. 4, (1505-1509), Online publication date: 1-Apr-2007.Läckgren G, Sköldenberg E and Stenberg A (2018) Endoscopic Treatment With Stabilized Nonanimal Hyaluronic Acid/Dextranomer Gel is Effective in Vesicoureteral Reflux Associated With Bladder DysfunctionJournal of Urology, VOL. 177, NO. 3, (1124-1129), Online publication date: 1-Mar-2007.Jung C, DeMarco R, Lowrance W, Pope J, Adams M, Dietrich M and Brock J (2018) Subureteral Injection of Dextranomer/Hyaluronic Acid Copolymer for Persistent Vesicoureteral Reflux Following UreteroneocystostomyJournal of Urology, VOL. 177, NO. 1, (312-315), Online publication date: 1-Jan-2007.Diamond D (2018) Editorial CommentsJournal of Urology, VOL. 176, NO. 6, (2653-2653), Online publication date: 1-Dec-2006.Benoit R, Peele P, Cannon G and Docimo S (2018) The Cost-Effectiveness of Dextranomer/Hyaluronic Acid Copolymer for the Management of Vesicoureteral Reflux. 2. Reflux Correction at the Time of Diagnosis as a Substitute for Traditional ManagementJournal of Urology, VOL. 176, NO. 6, (2649-2653), Online publication date: 1-Dec-2006.Vandersteen D, Routh J, Kirsch A, Scherz H, Ritchey M, Shapiro E, Wolpert J, Pfefferle H and Reinberg Y (2018) Postoperative Ureteral Obstruction After Subureteral Injection of Dextranomer/Hyaluronic Acid CopolymerJournal of Urology, VOL. 176, NO. 4, (1593-1595), Online publication date: 1-Oct-2006.Benoit R, Peele P and Docimo S (2018) The Cost-Effectiveness of Dextranomer/Hyaluronic Acid Copolymer for the Management of Vesicoureteral Reflux. 1: Substitution for Surgical ManagementJournal of Urology, VOL. 176, NO. 4, (1588-1592), Online publication date: 1-Oct-2006.Puri P, Pirker M, Mohanan N, Dawrant M, Dass L and Colhoun E (2018) Subureteral Dextranomer/Hyaluronic Acid Injection as First Line Treatment in the Management of High Grade Vesicoureteral RefluxJournal of Urology, VOL. 176, NO. 4S, (1856-1860), Online publication date: 1-Oct-2006.Lottmann H, Margaryan M, Lortat-Jacob S, Bernuy M and Läckgren G (2018) Long-Term Effects of Dextranomer Endoscopic Injections for the Treatment of Urinary Incontinence: An Update of a Prospective Study of 61 PatientsJournal of Urology, VOL. 176, NO. 4S, (1762-1766), Online publication date: 1-Oct-2006.Dawrant M, Mohanan N and Puri P (2018) Endoscopic Treatment for High Grade Vesicoureteral Reflux in InfantsJournal of Urology, VOL. 176, NO. 4S, (1847-1850), Online publication date: 1-Oct-2006.Lorenzo A, Salle J, Barroso U, Cook A, Grober E, Wallis M, Bägli D and Khoury A (2018) What are the Most Powerful Determinants of Endoscopic Vesicoureteral Reflux Correction? Multivariate Analysis of a Single Institution Experience During 6 YearsJournal of Urology, VOL. 176, NO. 4S, (1851-1855), Online publication date: 1-Oct-2006.Lottmann H, Margaryan M, Bernuy M, Grosz A, Aigrain Y, Lortat-Jacob S and Läckgren G (2018) Long-Term Effects of Dextranomer Endoscopic Injections for Treatment of Urinary Incontinence: An Update of a Prospective Study of 31 PatientsJournal of Urology, VOL. 175, NO. 4, (1485-1489), Online publication date: 1-Apr-2006.Elder J, Diaz M, Caldamone A, Cendron M, Greenfield S, Hurwitz R, Kirsch A, Koyle M, Pope J and Shapiro E (2018) Endoscopic Therapy for Vesicoureteral Reflux: A Meta-Analysis. I. Reflux Resolution and Urinary Tract InfectionJournal of Urology, VOL. 175, NO. 2, (716-722), Online publication date: 1-Feb-2006.Elmore J, Scherz H and Kirsch A (2018) Dextranomer/Hyaluronic Acid for Vesicoureteral Reflux: Success Rates After Initial Treatment FailureJournal of Urology, VOL. 175, NO. 2, (712-715), Online publication date: 1-Feb-2006.MISSERI R, CASALE A, CAIN M and RINK R (2018) ALTERNATIVE USES OF DEXTRANOMER/HYALURONIC ACID COPOLYMER: THE EFFICACY OF BLADDER NECK INJECTION FOR URINARY INCONTINENCEJournal of Urology, VOL. 174, NO. 4 Part 2, (1691-1694), Online publication date: 1-Oct-2005.PEREZ-BRAYFIELD M, KIRSCH A, HENSLE T, KOYLE M, FURNESS P and SCHERZ H (2018) ENDOSCOPIC TREATMENT WITH DEXTRANOMER/HYALURONIC ACID FOR COMPLEX CASES OF VESICOURETERAL REFLUXJournal of Urology, VOL. 172, NO. 4 Part 2, (1614-1616), Online publication date: 1-Oct-2004.CAPOZZA N, LAIS A, NAPPO S and CAIONE P (2018) THE ROLE OF ENDOSCOPIC TREATMENT OF VESICOURETERAL REFLUX: A 17-YEAR EXPERIENCEJournal of Urology, VOL. 172, NO. 4 Part 2, (1626-1629), Online publication date: 1-Oct-2004.KIRSCH A, PEREZ-BRAYFIELD M, SMITH E and SCHERZ H (2018) THE MODIFIED STING PROCEDURE TO CORRECT VESICOURETERAL REFLUX: IMPROVED RESULTS WITH SUBMUCOSAL IMPLANTATION WITHIN THE INTRAMURAL URETERJournal of Urology, VOL. 171, NO. 6 Part 1, (2413-2416), Online publication date: 1-Jun-2004.MORAN PENCO J, FRAILE A, ALARCON J, MERINO F, VELA D, RODRIGUEZ S and BRANTOT A (2018) Evolution of the Treatment of Vesicoureteral Reflux in SpainJournal of Urology, VOL. 171, NO. 2, (834-837), Online publication date: 1-Feb-2004.LÄCKGREN G, WÅHLIN N, SKÖLDENBERG E, NEVÉUS T and STENBERG A (2018) Endoscopic Treatment of Vesicoureteral Reflux With Dextranomer/Hyaluronic Acid Copolymer is Effective in Either Double Ureters or a Small KidneyJournal of Urology, VOL. 170, NO. 4 Part 2, (1551-1555), Online publication date: 1-Oct-2003.PURI P, CHERTIN B, VELAYUDHAM M, DASS L and COLHOUN E (2018) Treatment of Vesicoureteral Reflux by Endoscopic Injection of Dextranomer/Hyaluronic Acid Copolymer: Preliminary ResultsJournal of Urology, VOL. 170, NO. 4 Part 2, (1541-1544), Online publication date: 1-Oct-2003.KIRSCH A, PEREZ-BRAYFIELD M and SCHERZ H (2018) Minimally Invasive Treatment of Vesicoureteral Reflux with Endoscopic Injection of Dextranomer/Hyaluronic Acid Copolymer: The Children’s Hospitals of Atlanta ExperienceJournal of Urology, VOL. 170, NO. 1, (211-215), Online publication date: 1-Jul-2003.CHERTIN B, DE CALUWÉ D and PURI P (2018) Endoscopic Treatment of Primary Grades IV and V Vesicoureteral Reflux in Children With Subureteral Injection of PolytetrafluoroethyleneJournal of Urology, VOL. 169, NO. 5, (1847-1849), Online publication date: 1-May-2003.KOBELT G, CANNING D, HENSLE T and LÄCKGREN G (2018) The Cost-Effectiveness of Endoscopic Injection of Dextranomer/Hyaluronic Acid Copolymer for Vesicoureteral RefluxJournal of Urology, VOL. 169, NO. 4, (1480-1485), Online publication date: 1-Apr-2003.STENBERG A, LARSSON E and LÄCKGREN G (2018) Endoscopic Treatment with Dextranomer-Hyaluronic Acid for Vesicoureteral Reflux: Histological FindingsJournal of Urology, VOL. 169, NO. 3, (1109-1113), Online publication date: 1-Mar-2003.Caione P and Capozza N (2018) Endoscopic Treatment of Urinary Incontinence in Pediatric Patients: 2-Year Experience with Dextranomer/Hyaluronic Acid CopolymerJournal of Urology, VOL. 168, NO. 4 Part 2, (1868-1871), Online publication date: 1-Oct-2002.Lottmann H, Margaryan M, Bernuy M, Rouffet M, Bau M, El-Ghoneimi A, Aigrain Y, Stenberg A and Läckgren G (2018) The Effect of Endoscopic Injections of Dextranomer Based Implants on Continence and Bladder Capacity: A Prospective Study of 31 PatientsJournal of Urology, VOL. 168, NO. 4 Part 2, (1863-1867), Online publication date: 1-Oct-2002.Capozza N, Lais A, Matarazzo E, Nappo S, Patricolo M and Caione P (2018) Influence of Voiding Dysfunction on the Outcome of Endoscopic Treatment for Vesicoureteral RefluxJournal of Urology, VOL. 168, NO. 4 Part 2, (1695-1698), Online publication date: 1-Oct-2002. (2018) EDITORIAL COMMENTJournal of Urology, VOL. 167, NO. 3, (1445-1446), Online publication date: 1-Mar-2002. Volume 166Issue 5November 2001Page: 1887-1892 Advertisement Copyright & Permissions© 2001 by American Urological Association, Inc.Keywordsendoscopyureterhyaluronic acidchildvesico-ureteral refluxMetricsAuthor Information GÖRAN LÄCKGREN More articles by this author NILS WÅHLIN More articles by this author ERIK SKÖLDENBERG More articles by this author ARNE STENBERG More articles by this author Expand All Advertisement PDF downloadLoading ..." @default.
• W4361745362 created "2023-04-04" @default.
• W4361745362 creator A5007561715 @default.
• W4361745362 creator A5012890738 @default.
• W4361745362 creator A5078588185 @default.
• W4361745362 creator A5085287412 @default.
• W4361745362 date "2001-11-01" @default.
• W4361745362 modified "2023-10-18" @default.
• W4361745362 title "LONG-TERM FOLLOWUP OF CHILDREN TREATED WITH DEXTRANOMER/HYALURONIC ACID COPOLYMER FOR VESICOURETERAL REFLUX" @default.
• W4361745362 cites W1974970119 @default.
• W4361745362 cites W1981201374 @default.
• W4361745362 cites W1983369450 @default.
• W4361745362 cites W1993580081 @default.
• W4361745362 cites W1995222300 @default.
• W4361745362 cites W1998885067 @default.
• W4361745362 cites W2040408808 @default.
• W4361745362 cites W2057974242 @default.
• W4361745362 cites W2060880870 @default.
• W4361745362 cites W2067842230 @default.
• W4361745362 cites W2087229423 @default.
• W4361745362 cites W2088863857 @default.
• W4361745362 cites W2117167481 @default.
• W4361745362 cites W2134689014 @default.
• W4361745362 cites W2150460641 @default.
• W4361745362 cites W2297020899 @default.
• W4361745362 cites W2410388892 @default.
• W4361745362 cites W2413955274 @default.
• W4361745362 cites W2416022336 @default.
• W4361745362 cites W3145367840 @default.
• W4361745362 cites W4206488668 @default.
• W4361745362 cites W69771 @default.
• W4361745362 doi "https://doi.org/10.1016/s0022-5347(05)65713-8" @default.
• W4361745362 hasPublicationYear "2001" @default.
• W4361745362 type Work @default.
• W4361745362 citedByCount "189" @default.
• W4361745362 countsByYear W43617453622012 @default.
• W4361745362 countsByYear W43617453622013 @default.
• W4361745362 countsByYear W43617453622014 @default.
• W4361745362 countsByYear W43617453622015 @default.
• W4361745362 countsByYear W43617453622016 @default.
• W4361745362 countsByYear W43617453622017 @default.
• W4361745362 countsByYear W43617453622018 @default.
• W4361745362 countsByYear W43617453622019 @default.
• W4361745362 countsByYear W43617453622020 @default.
• W4361745362 countsByYear W43617453622021 @default.
• W4361745362 countsByYear W43617453622022 @default.
• W4361745362 countsByYear W43617453622023 @default.
• W4361745362 crossrefType "journal-article" @default.
• W4361745362 hasAuthorship W4361745362A5007561715 @default.
• W4361745362 hasAuthorship W4361745362A5012890738 @default.
• W4361745362 hasAuthorship W4361745362A5078588185 @default.
• W4361745362 hasAuthorship W4361745362A5085287412 @default.
• W4361745362 hasConcept C105702510 @default.
• W4361745362 hasConcept C121332964 @default.
• W4361745362 hasConcept C126322002 @default.
• W4361745362 hasConcept C126894567 @default.
• W4361745362 hasConcept C141071460 @default.
• W4361745362 hasConcept C2777529286 @default.
• W4361745362 hasConcept C2777609623 @default.
• W4361745362 hasConcept C2779134260 @default.
• W4361745362 hasConcept C43270747 @default.
• W4361745362 hasConcept C61797465 @default.
• W4361745362 hasConcept C62520636 @default.
• W4361745362 hasConcept C71924100 @default.
• W4361745362 hasConceptScore W4361745362C105702510 @default.
• W4361745362 hasConceptScore W4361745362C121332964 @default.
• W4361745362 hasConceptScore W4361745362C126322002 @default.
• W4361745362 hasConceptScore W4361745362C126894567 @default.
• W4361745362 hasConceptScore W4361745362C141071460 @default.
• W4361745362 hasConceptScore W4361745362C2777529286 @default.
• W4361745362 hasConceptScore W4361745362C2777609623 @default.
• W4361745362 hasConceptScore W4361745362C2779134260 @default.
• W4361745362 hasConceptScore W4361745362C43270747 @default.
• W4361745362 hasConceptScore W4361745362C61797465 @default.
• W4361745362 hasConceptScore W4361745362C62520636 @default.
• W4361745362 hasConceptScore W4361745362C71924100 @default.
• W4361745362 hasIssue "5" @default.
• W4361745362 hasLocation W43617453621 @default.
• W4361745362 hasOpenAccess W4361745362 @default.
• W4361745362 hasPrimaryLocation W43617453621 @default.
• W4361745362 hasRelatedWork W1964846374 @default.
• W4361745362 hasRelatedWork W2020919552 @default.
• W4361745362 hasRelatedWork W2029020359 @default.
• W4361745362 hasRelatedWork W2043713813 @default.
• W4361745362 hasRelatedWork W2071193357 @default.
• W4361745362 hasRelatedWork W2161111787 @default.
• W4361745362 hasRelatedWork W2418786254 @default.
• W4361745362 hasRelatedWork W2463448150 @default.
• W4361745362 hasRelatedWork W3094978056 @default.
• W4361745362 hasRelatedWork W4237861990 @default.
• W4361745362 hasVolume "166" @default.
• W4361745362 isParatext "false" @default.
• W4361745362 isRetracted "false" @default.
• W4361745362 workType "article" @default.